Literature DB >> 29602699

Intramedullary versus extramedullary internal fixation for unstable intertrochanteric fracture, a meta-analysis.

Xi Yu1, Hong Wang2, Xin Duan2, Ming Liu2, Zhou Xiang3.   

Abstract

OBJECTIVE: The aim of this meta-analysis was to explore the difference between and compare intramedullary fixation (IF) and extramedullary fixation (EF) for unstable intertrochanteric fractures.
METHODS: We searched Pubmed database and Cochrane library following by including and excluding articles based from inception to December, 2016. All randomized controlled trials (RCTs) comparing IF and EF for unstable intertrochanteric fractures were assessed and selected by two researchers independently. Data were analyzed using Review Manager 5.1 version.
RESULTS: 17 RCTs were enrolled in our meta-analysis comparing IF and EF and showed evidence that IF had lower rate of implant failure RR = 0.2695%CI 0.13-0.51, P < 0.0001 and re-operation (RR = 0.60, 95%CI 0.37-0.98, P = 0.04), while there was no statistical differences of cut-out, postoperative infections and other complications. Moreover, PPM scores verified that IF had better postoperative hip mobility recovery (MD = 0.87, 95%CI 0.08-1.66, P = 0.03).
CONCLUSION: IF has lower incidence of failure of implant and reoperation and shows better postoperative functional recovery when treating adult unstable intertrochanteric fracture while the most postoperative complications were not statistically different from EF. LEVEL OF EVIDENCE: Level I, therapeutic study.
Copyright © 2018 Turkish Association of Orthopaedics and Traumatology. Production and hosting by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Extramedullary fixation; Internal fixation; Intramedullary fixation; Tip-apex distance; Unstable intertrochanteric fracture

Mesh:

Year:  2018        PMID: 29602699      PMCID: PMC6150441          DOI: 10.1016/j.aott.2018.02.009

Source DB:  PubMed          Journal:  Acta Orthop Traumatol Turc        ISSN: 1017-995X            Impact factor:   1.511


Introduction

Intertrochanteric fractures are one of the elementary orthopedic clinical problems, that are commonly resulted from low energy injuries and lead to severe functional defects and heavy socioeconomic pressure. The incidence of intertrochanteric fracture has been kept increasing recently and the mortality rate maintains 30% within 5 years after fracture. The internal fixations are usually considered as prior options for treatments that can enable the patient to have postoperative early mobilization, good functional recovery and less complications.3, 4 With the time of invention and promotion internal fixation devices, the diversity of devices brings orthopedic surgeons more choices, such as intramedullary fixation (IF) (e.g. gamma nail, PFNA) or extramedullary fixation (EF) (e.g. SHS, CHS).5, 6, 7 Since intertrochanteric is an essential area connecting the femoral head and the shaft, the stability of this area is the key goal that orthopedic surgeons should achieve. Recently, the classification of intertrochanteric fracture is based on the stability of this area. Stable intertrochanteric fractures are commonly simple fractures which are less affected by vertical stress during one-leg standing while unstable intertrochanteric fracture always have affected posteromedial or lateral femoral cortex that decreased the resistibility to stress.8, 9 However, even with increasing number of clinical trials comparing IF with EFfor treating unstable intertrochanteric fracture, the reported results still have not reached the consistency.10, 11, 12 Although there were several systematic reviews and meta-analysis comparing the differences between two kinds internal fixation devices, the findings are still in need of more evidence.13, 14, 15 In the same time, novel devices and surgeon's experience with device also updates with time. Thus, in this study, we conducted a mate-analysis to achieve a detailed comparison and evaluation of IF and EF for unstable intertrochanteric fractures.

Materials and methods

Interventions

IF represents an internal fixation with an intramedullary nail inserting into the femoral bone marrow cavity, for instance intramedullary hip screw (IMHS), gamma nail (GN), proximal femoral nail (PFN), Targon proximal femoral nail (Targon PFN), proximal femoral nail anti-rotation (PFNA), Holland nail and INTERTAN nail (INT), while EF including Sliding hip screw (SHS), as known as Richard screw or AMBI screw, Dynamic hip screw (DHS), Compression hip screw (CHS), Medoff sliding plate (MSP), Percutaneous compression plating (PCCP), Locking compression plate (LCP) and Less invasive stabilization systems (LISS), stands for internal fixations applied outside the marrow cavity for reduction and stabilization. In this meta-analysis, we categorized IF and EF groups to maintain the information integrity according to Cochrane collaboration.

Search strategy

The database of PubMed database and Cochrane Central Register of Controlled Trials (CENTRAL) were searched from inception up to Jan, 31, 2017. We developed search strategy with target items as followed, #1 “Trochanteric Fractures”, “Fractures, Trochanteric”, “Intertrochanteric Fracture”, “Fractures, Intertrochanteric”, “Hip Fractures”; #2 “Fracture Fixation, Intramedullary”, “Fixations, Intramedullary Fracture”, “Fracture Fixations, Intramedullary”, “Intramedullary Fracture Fixation”, “Intramedullary Fracture Fixations”, “Osteosynthesis, Fracture, Intramedullary”, “Intramedullary Nailing”, “Intramedullary Nailings”, “Nailings, Intramedullary”, “Nailing, Intramedullary”, #3 “Fixation, Internal Fracture”, “Fixations, Internal Fracture”, “Fracture Fixations, Internal”, “Internal Fracture Fixation”, “Internal Fracture Fixations”, “Osteosynthesis, Fracture”, “Fracture Osteosyntheses”, “Fracture Osteosynthesis”, “Osteosyntheses, Fracture”,#3 “Fracture Fixation, Internal”, “Fixation, Internal Fracture”, “Fixations, Internal Fracture”, “Fracture Fixations, Internal”, “Internal Fracture Fixation”, “Internal Fracture Fixations”, “ Osteosynthesis, Fracture”, “Fracture Osteosyntheses”, “Fracture Osteosynthesis”, “Osteosyntheses, Fracture”; #4 “randomized controlled trial”, “randomized [Title/Abstract] OR placebo [Title/Abstract]”.

Inclusion and exclusion criteria

Prospective randomized controlled clinical trials (RCTs) comparing IF and EF for treating unstable intertrochanteric fractures in adults were considered being enrolled as shown in Flowchart (Fig. 1). Unstable intertrochanteric fractures were categorized according to AO/OTA classification (AO/OTA 31 A2.2-A3) and Evans-Jensen classification (II—V type). RCTs published in English with related titles and abstracts were screened by two independent reviewers.
Fig. 1

Flowchart of methodological search strategy and inclusion and exclusion criteria.

Flowchart of methodological search strategy and inclusion and exclusion criteria.

Outcomes of interest

The potential outcomes of interest included intraoperative and postoperative indexes. Intraoperative indexes were Cleveland zone and tip-apex distance (TAD) while postoperative indexes included adverse events, such as cut-out, fracture of femoral shaft, re0peration, failure of the implant, other complications and hip functional evaluation scores, Harris hip score (HHS) and Parker Palmer hip mobility (PPM).17, 18

Risk of bias assessment and data extraction

Two independent reviewers screened the abstracts and full-text of eligible studies to evaluate the risk of bias of included researches using a tool recommended by Cochrane collaboration. For evaluating the surgeon's experience on using devices, a “high” would be marked if there was not enough information whether the research avoided learning curve problem.

Statistical analysis

Review Manager 5.3 software was employed to process statistical analysis. Continuous data was calculated with weighted mean difference (MD) while dichotomous data calculated with relative risk (RR). Both results adopted a corresponding 95% confidence interval (CI). A P value of <50% was considered significant. The heterogeneity was evaluated between comparisons though I-square (I2) test and Chi-square (X2) test. A fixed effect model was applied when I2<50% otherwise a random effect model was enabled.

Results

Characteristics of the studies

17 RCTs were recruited based on the search strategy and inclusion and exclusion criteria. In total, 2653 cases with average age ranging from 53.95 to 84.6 were enrolled, of which the sample number ranged from 12 to 203 cases. Table 1.
Table 1

Characteristics of included studies.

IntervenSample sizem/fAgeStableUnstableFollow-up
AuthoryearIFEFIFEFIFEFIFEFIFEFIFEF/month
Aktselis2014GNABMI404012/2812/2882. ± 5.883.1 ± 6.5NANA404012
Barton2010LGNSHS10011019/8125/8583.1 (42–99)83.3 (56–97)NANA10011012
Baumgaertn1998IMHSCHS6768NANANANA3136353324
Ekström2007PFNMSP1059825/8025/7382 (48–96)82 (52–97)NANA828712
garg2011PFNADHS423932/1012/2760.2 (60–80)64.3 (60–78)NANA423912
Haq2014PFNDFLCP202010/1018/255.55 ± 17.0953.95 ± 14.75NANA202012
Harrington2002IMHSCHS505210/4011/4183.8 ± 8.582.1 ± 8.6NANA505012
Leung1992GNDHS939326/6830/6380.86 ± 8.4178.27 ± 9.46302063736.8–7.5
Miedel2005GNMSP109108NANA84.6 ± 0.682.7 ± 0.6NANA939612
Papasimos2005PFNAMBI404017/2314/2679.481.4NANA404012
Reindl2015GN/INT/TNDHS1129257/5531/61NANANANA1129212
Sadowski2002PFNDCS2031977/135/1480 ± 1377 ± 14NANA201912
Tao2013PFNALISS21215/1611/1082.5 ± 7.980.7 ± 8.1NANA212113
Tao2013PFNALISS14125/94/877.4 ± 6.377.2NANA141213
Utrilla2005GNCHS104106NANANANANANA233113.6 (12–30)
verettas2010GNDHS595920/4015/5479.22 ± 7.9981.03 ± 6.38NANA595910days
Zehir2014PFNADHS9610237/5939/6377.22 ± 6.8276.86 ± 6.74NANA961026
Zou2009PFNADHS586312/4615/4765 (37–91)65 (34–89)4252161112
Characteristics of included studies.

Position of implant and tip-apex distance (TAD)

The Cleveland zone and TAD of IF and EF group was evaluated on postoperative radiographs according to the introduction and description of Parker and Baumgeartner.20, 21 The ideal cephalic implant position as known as Cleveland zone was confirmed to be “center-center” position. There were 5 RCTs provided proper data of Cleveland zone of both internal fixation devices as shown in Fig. 2.22, 23, 24, 25 It showed that there was no difference of number of Cleveland zone between IF and EF group (RR = 0.96, 95%CI 0.87–1.05, P = 0.36) and no evidence of heterogeneity (Chi2 = 1.20, df = 3, P = 0.75, I2 = 0%). As shown in Fig. 3, 3 RCTs measured and the TAD for both groups. It showed that TAD value is significant higher in IF group than that in EF group (MD = 0.85 95%CI 0.08–1.62, P = 0.03) and no evidence for heterogeneity (Chi2 = 1.45, df = 2. P = 0.48, I2 = 0%).
Fig. 2

The comparison of position of implant between IF and EF groups.

Fig. 3

The comparison of TAD between IF and EF groups.

The comparison of position of implant between IF and EF groups. The comparison of TAD between IF and EF groups.

Cut-out

10 RCTs concerned about the most important complication, cut-out.22, 23, 24, 25, 26, 27, 28, 29, 30, 31 Totally, 1409 patients were involved in this meta-analysis, the result showed that the incidence of cut out had no significant difference between two kinds devices without evidence of heterogeneity (RR = 0.67, 95%CI 0.40–1.12, P = 0.12, Chi2 = 9.87, df = 9, P = 0.36, I2 = 9%) (shown in Fig. 4.).
Fig. 4

The comparison of cut-out between IF and EF groups.

The comparison of cut-out between IF and EF groups.

Failure of implant

8 RCTs pointed out the failure of implant which would lead to severe consequences to the stability and function of the affected limb as shown in Fig. 5.23, 24, 26, 29, 30, 31, 32, 33 The IF group had significantly less failure of implant than EF group (RR = 0.26, 95%CI 0.13–0.51, P < 0.0001). No evidence of significant heterogeneity was found (Chi2 = 6.74, df = 7, P = 0.46, I2 = 0%).
Fig. 5

The comparison of failure of implant between IF and EF groups.

The comparison of failure of implant between IF and EF groups.

Fracture of the femoral shaft

There were 12 RCTs providing data of postoperative fracture of femoral shaft with 2936 patients included.22, 27, 28, 31, 34, 35, 36, 37, 38, 39, 40, 41 As shown in Fig. 6, even though there were more cases of fracture of femoral shaft reported, this difference was not statistically different between IF and EF groups (RR = 2.84, 95%CI 0.69–11.77, P = 0.15). No evidence of heterogeneity was found in this comparison (Chi2 = 0.03, df = 3, P = 0.82, I2 = 0%).
Fig. 6

The comparison of fracture of femoral shaft between IF and EF groups.

The comparison of fracture of femoral shaft between IF and EF groups.

Reoperation

10 RCTs reported the adverse event numbers of reoperation as shown in Fig. 7.22, 23, 24, 25, 26, 29, 30, 31, 33, 42 1351 cases were involved and our results indicated that IF group had significantly lower incidence of reoperation than EF group (RR = 0.60, 95%CI 0.37–0.98, P = 0.04) and no significant heterogeneity was found between groups (Chi2 = 12.89, df = 9, P = 0.17, I2 = 30%).
Fig. 7

The comparison of reoperation rate between IF and EF groups.

The comparison of reoperation rate between IF and EF groups.

Postoperative infection

We pooled data of infections including superficial infection, deep infection and general infection for this meta-analysis. In total, 11 RCTs were involved in this analysis.24, 25, 27, 30, 31, 33, 38, 42, 43, 44, 45 After analyzing, we found that the incidences of superficial infection (RR = 0.77, 95%CI 0.46–1.30,P = 0.33) and general infection (RR = 0.87, 95%CI 0.46–1.64,P = 0.66) between two groups had no statistically significant while IF group had less deep infection (RR = 0.20, 95%CI 0.04–0.92, P = 0.04). Within all comparisons, no heterogeneity was found (shown in Fig. 8).
Fig. 8

The comparisons of superficial infection, deep infection and general infection between IF and EF groups.

The comparisons of superficial infection, deep infection and general infection between IF and EF groups.

Other complications

We pooled data for other adverse events, for instance postoperative DVT, fracture non-union and hip pain complain, and compared between IF and EF groups. In Fig. 9, it showed that regarding to other adverse events recorded in both groups, no significant difference was found among postoperative DVT (RR = 1.01, 95%CI 0.47–2.20, P = 0.97), fracture non-union (RR = 0.40, 95%CI 0.12–1.38, P = 0.15) and hip pain (RR = 1.06, 95%CI 0.50–2.26, P = 0.88), and No heterogeneity was indicated among these comparisons.
Fig. 9

The comparisons of other complications between IF and EF groups.

The comparisons of other complications between IF and EF groups.

Hip functional evaluation

There were 3 RCTs demonstrating their evaluation and assessment of postoperative hip function.33, 43, 44 They measured the HHS and PPM score system. However, after analyzing the data respectively, we found no statistical difference though HHS (MD = 4.41, 95%CI −3.81–12.62, P = 0.29), but a significant difference though PPM score (MD = 0.87, 95%CI 0.08–1.66, P = 0.03), revealing that patient received IF devices could have better hip function scores than who received EF devices. A high heterogeneity was found in HHS comparison meanwhile no heterogeneity was detected in PPM analysis (Fig. 10, Fig. 11).
Fig. 10

The comparison of HHS between IF and EF groups.

Fig. 11

The comparison of PPM between IF and EF groups.

The comparison of HHS between IF and EF groups. The comparison of PPM between IF and EF groups.

Discussion

The proper and ideal treatment for unstable intertrochanteric fractures are still remaining the top problems for orthopedic surgeons all over the world.46, 47 Researches have illustrated that due to the fractures of proximal femoral medial cortex wall, the stress load to implant as well as the risk of implant failure would increase. Furthermore, it was reported that the failure of implant would be increased by using SHS for in AO/OTA 31A3 type intertrochanteric fracture. A recent Cochrane systematic review and meta-analysis conducted by Parker et al pointed out that for stable intertrochanteric fracture, either IF and EF can achieve good reduction and stabilization results. On the other hand, for unstable fracture, they recommended the usage of IF prior to EF with the lack of functional comparison and more solid evidence. Thus, in this meta-analysis, we intended to recruit latest published RCTs concerning about the IF and EF devices treating unstable intertrochanteric fractures. We have developed search strategy and followed the direction of Cochrane collaboration guidelines. After restricted search and screen, 17 eligible RCTs were included with totally 2653 cases. Among them, Baumgaertner, Leung and Zou studied both stable and unstable intertrochanteric fracture with separated results.22, 38, 42 Since the internal fixation becomes one of the mainstream surgical treatments for intertrochanteric fracture, clinical trials for testing and applying different internal fixation devices with different constructions have been continued all the time. With updating and renovating of internal fixations, intra- and extra-medullary fixations could be categorized based on their implant design. However, the cut-out of the cephalic implant after surgery has remained a main complication for both IF and EF devices.49, 50 Our meta-analysis found no statistical significant difference of cut-out between IF and EF groups, which was consistence with previous studies.14, 15 Besides cut-out, bone non-union, infection and other complications were taken into this research as well. Previous evidence-based study indicated that IF device GN might lead to more complications that EF device SHS, but our latest data uncovered that although IF devices held lower rate of deep infection, other complications including fracture non-union, DVT, superficial and general infections and postoperative hip pain did not demonstrated significant different. TAD and Cleveland zone are considered as important factors related to cephalic implant cut-out.51, 52, 53 TAD was measured according to AP and lateral view radiographs and calculated as the summation of the distance from the tip of the cephalic implant to the apex of the femoral head on both views. Studies proposed the maximal safe distance was 25 mm. TAD>25 mm would be regarded with high risk of cut-out. In this meta-analysis, comparisons on TAD showed that IF group had higher mean TAD value. However, the average TADs of IF and EF groups were neither >25 mm, we can't directly connect the TAD to cut-out risk. In the meantime, Cleveland zone comparison showed that IF and EF groups had similar implant placement. Comprehensively, both TAD and Cleveland zone showed similar outcome of cut-out. The cut-out between IF and EF groups had no significant difference. What is also noteworthy in this meta-analysis, our results testified that IF had less adverse events, such as failure of implant, reoperation and deep infection. Failure of implant represented mechanical failures, such as cut-out, implant breakage, non-union, surgical related secondary fracture of the femoral shaft. Our analysis clearly showed that IF had lower incidence of failure of implant. The possible explanation would be IF device's loading sharing design, the occurrence of intraoperative fracture of the lateral trochanteric wall leading to extra stress on the distal femoral fragment and the difficulty of reduction.29, 31 The hip function recovery was evaluated by two hip function and mobility score systems, HHS and PPM. Respectively, each comparison contains two RCTs. Although the HHS stated no significant difference, the PPM showed that IF group had better hip mobility after surgery. More RCTs reporting hip functional recovery status are needed for more solid evidence. During researching and assessing the effect of IF and EF internal fixations, the learning curve problem of surgeons participating in the operations should be paid closed attention, which might affect the evaluation of RCTs. As the IF is relatively new technique, the familiarity of one surgeon with two devices would have great impacts during surgeon's performance and application. It may lead to the unnecessary intraoperative fractures around the insertion area. Utrilla et al specified the learning curve issue about using GN, but for now, there was no suitable RCT and evidence-based study concerning about the learning curve and fixation effect. In this meta-analysis, we conducted a comprehensive comparison and analysis following the methodological directions from Cochrane collaboration. However, there are still some limitations. Multiple lingual researches should be expanded and screened. More specified comparisons between individual internal fixation device are in need of stronger evidence.

Conclusion

Above all, the lower rate of failure of implant, reoperation and deep infection, the similar other adverse event and better postoperative hip mobility recovery demonstrated the priority of using IF when treating unstable intertrochanteric fractures.

Conflicts of interest

All authors declare that there is no conflict of interest in this study.
  52 in total

1.  A randomised comparison of AMBI, TGN and PFN for treatment of unstable trochanteric fractures.

Authors:  S Papasimos; C M Koutsojannis; A Panagopoulos; P Megas; E Lambiris
Journal:  Arch Orthop Trauma Surg       Date:  2005-09       Impact factor: 3.067

2.  The new proximal femoral nail antirotation (PFNA) in daily practice: results of a multicentre clinical study.

Authors:  R K J Simmermacher; J Ljungqvist; H Bail; T Hockertz; A J H Vochteloo; U Ochs; Chr v d Werken
Journal:  Injury       Date:  2008-06-25       Impact factor: 2.586

Review 3.  Epidemiology of hip fractures.

Authors:  R G Cumming; M C Nevitt; S R Cummings
Journal:  Epidemiol Rev       Date:  1997       Impact factor: 6.222

4.  Accuracy of the surgeon's eye: use of the tip-apex distance in clinical practice.

Authors:  Jonathan Wright; Steven Kahane; Abdul Moeed; Andrew MacDowell
Journal:  Injury       Date:  2015-05-08       Impact factor: 2.586

Review 5.  Nailing intertrochanteric hip fractures: short versus long; locked versus nonlocked.

Authors:  Nikolaos K Kanakaris; Theodoros H Tosounidis; Peter V Giannoudis
Journal:  J Orthop Trauma       Date:  2015-04       Impact factor: 2.512

6.  A new intramedullary nail device for the treatment of intertrochanteric hip fractures: Perioperative experience.

Authors:  Peter Bienkowski; Rudolf Reindl; Gregory K Berry; Elena Iakoub; Edward J Harvey
Journal:  J Trauma       Date:  2006-12

7.  Prospective randomized study comparing two cephalomedullary nails for elderly intertrochanteric fractures: Zimmer natural nail versus proximal femoral nail antirotation II.

Authors:  Young-Soo Shin; Jin-Eon Chae; Tae-Wook Kang; Seung-Beom Han
Journal:  Injury       Date:  2017-04-13       Impact factor: 2.586

8.  A prospective randomised comparison of the dynamic hip screw and the gamma locking nail.

Authors:  P J Radford; M Needoff; J K Webb
Journal:  J Bone Joint Surg Br       Date:  1993-09

Review 9.  Tip to apex distance in femoral intertrochanteric fractures: a systematic review.

Authors:  Jorge Rubio-Avila; Kim Madden; Nicole Simunovic; Mohit Bhandari
Journal:  J Orthop Sci       Date:  2013-05-02       Impact factor: 1.601

Review 10.  Unstable intertrochanteric hip fractures in the elderly.

Authors:  Dieter M Lindskog; Michael R Baumgaertner
Journal:  J Am Acad Orthop Surg       Date:  2004 May-Jun       Impact factor: 3.020

View more
  13 in total

1.  [Reasons of the guide pin eccentricity of helical blade during proximal femoral nail anti-rotation internal fixation for femoral intertrochanteric fractures].

Authors:  Xin Wang; Yingqi Zhang; Shouchao Du; Shimin Zhang; Kai Chen; Zhiyuan Wang; Feng Yuan; Liming Cheng
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2021-08-15

2.  External fixation via the anterior inferior iliac spine for proximal femoral fractures in young patients.

Authors:  Qing Yang; Nong Chen; Wenqin Fu
Journal:  Open Med (Wars)       Date:  2021-08-04

3.  Incidence and risk factors of surgical site infection after intertrochanteric fracture surgery: A prospective cohort study.

Authors:  Kuo Zhao; Junzhe Zhang; Junyong Li; Hongyu Meng; Zhongzheng Wang; Yanbin Zhu; Zhiyong Hou; Yingze Zhang
Journal:  Int Wound J       Date:  2020-08-24       Impact factor: 3.315

4.  [Treatment of peri-implant refracture after intramedullary nail fixation for intertrochanteric fractures].

Authors:  Lin Teng; Yongchuan Xiao; Gang Zhong
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2021-03-15

Review 5.  Revision surgery due to failed internal fixation of intertrochanteric femoral fracture: current state-of-the-art.

Authors:  Pei Liu; Dongxu Jin; Changqing Zhang; Youshui Gao
Journal:  BMC Musculoskelet Disord       Date:  2020-08-22       Impact factor: 2.362

Review 6.  Cephalo-medullary nailing versus dynamic hip screw with trochanteric stabilisation plate for the treatment of unstable per-trochanteric hip fractures: a meta-analysis.

Authors:  Amr Selim; Nikhil Ponugoti; Ali Zain Naqvi; Henry Magill
Journal:  J Orthop Surg Res       Date:  2021-01-11       Impact factor: 2.359

7.  [Effectiveness of proximal femoral nail anti-rotation combined with minimally invasive percutaneous plate osteosynthesis versus Intertan intramedullary nail fixation in treatment of intertrochanteric fracture with incomplete lateral wall].

Authors:  Zhangxin Chen; Cuiyu Hu; Zhenhua Zheng; Huixiang Jiang; Mingming Gao; Benwen Wu; Guofeng Huang; Zhenqi Ding
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2020-09-15

8.  Comparison of clinical outcomes with proximal femoral nail anti-rotation versus InterTAN nail for intertrochanteric femoral fractures: a meta-analysis.

Authors:  Wei Liu; Jie Liu; Guangrong Ji
Journal:  J Orthop Surg Res       Date:  2020-10-29       Impact factor: 2.359

9.  Bipolar Hemiarthroplasty should not be selected as the primary option for intertrochanteric fractures in elderly patients aged 85 years or more.

Authors:  Wen-Le Tan; Yan-Xin Shi; Jing-Yi Zhang; Chan-Rui Tang; Qing-Bin Guan; Jian-Ji Tan
Journal:  Medicine (Baltimore)       Date:  2020-09-11       Impact factor: 1.817

10.  The suitable fixation for unstable intertrochanteric fractures: A protocol of comparative clinical study.

Authors:  Yu Bo; Yue Qin; Yuan Zang; Haibo Yang
Journal:  Medicine (Baltimore)       Date:  2020-10-30       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.